Health Education Review Committee (HERC)



The ABC's of prostate cancer. 
Download the brochures here.
HERC is a new committee that will work on both a national and regional level with the Support Services Department to:
  • Review new and existing health education material published by PCC.
  • Advise on and contribute to the continuous development of education resources (e.g., paper based, electronic/interactive tools and mobile applications).
  • Review funding proposals received by PCC.
  • Make recommendations to address gaps in health education materials related to prostate cancer.
  • Assist in the distribution and promotion of health education materials.
  • Assist in developing monitoring and evaluation tools to assess the outcome of health education materials.
  • Act as PCC ambassadors to the public, medical, scientific and academic communities.

Who is on HERC?

The current membership reflects a wide array of experience and knowledge and includes the following:

Roberta Casabon, Peer-to-peer and Caregiver Support Volunteer, Toronto
Joe Chin (co-chair), London Health Sciences Centre, London
Nicole Culos-Reed, University of Calgary, Calgary
Joyce Davison, University of Saskatchewan, Saskatoon
Bryan Donnelly, University of Calgary, Calgary
Brian Gamble, University of Western Ontario, London
Winston Isaac, Walnut Foundation, Toronto
Leah Jamnicky, Princess Margaret Hospital, Toronto
Marilyn Junnila, Prostate Cancer Canada Network Advisory Council (PCCNAC) and PCCN Thunder Bay, Thunder Bay
Louis Lacombe, Centre Hospitalier Universitaire de Québec - L'Hotel-Dieu de Québec, Quebec City
George Main, PCCN Surrey, Surrey
Andrew Matthew, Princess Margaret Hospital, Toronto
Scott North, University of Alberta, Edmonton
John Oliffe, University of British Columbia, Vancouver
Tom Pickles, BC Cancer Agency, Vancouver
Maureen Rowlands (co-chair), Prostate Cancer Canada, Toronto
Sandra Vamos, Simon Fraser University, Burnaby
Colleen Young, Canadian Virtual Hospice, Toronto


Subscribe to our free monthly e-newsletter!

* indicates required

 



PCC Spotlight
New test developed to detect men at high risk of prostate cancer recurrence

Vienna, Austria: A new genetic “signature” to identify prostate cancer patients who are at high risk of their cancer recurring after surgery or radiotherapy has been developed by researchers in Canada, the 33rd conference of the European Society for Radiotherapy and Oncology (ESTRO33) in Vienna will hear today (Saturday). More

CanCertainty for All: Cancer’s Not Fair, But Accessing Treatment Should Be

Toronto, ON – March 10, 2014 – There is no disputing a cancer diagnosis is among the worst news a person or their family could receive. More

$1.8 Million awarded to Movember Rising Stars Supporting Innovators in Prostate Cancer Research

Toronto, ON – February 12, 2014 – Prostate Cancer Canada (PCC) is proud to announce the recipients of its 2014 Movember Rising Star awards in prostate cancer research. More

Support for Those Affected by Prostate Cancer

Toronto, ON - January 28, 2014 – We are pleased to announce a partnership between Prostate Cancer Canada and the Canadian Cancer Society in launching the Prostate Cancer Information Service (PCIS), which provides support to anyone affected by prostate cancer. More


Click here for news archive